Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia

NCT03197064 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Postoperative Nausea

Interventions

DRUG: Fosaprepitant 150 mg

Sponsor

Stanford University